Akihiro Bessho

2.0k total citations
92 papers, 1.4k citations indexed

About

Akihiro Bessho is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, Akihiro Bessho has authored 92 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 77 papers in Pulmonary and Respiratory Medicine, 66 papers in Oncology and 11 papers in Surgery. Recurrent topics in Akihiro Bessho's work include Lung Cancer Treatments and Mutations (65 papers), Lung Cancer Research Studies (38 papers) and Lung Cancer Diagnosis and Treatment (26 papers). Akihiro Bessho is often cited by papers focused on Lung Cancer Treatments and Mutations (65 papers), Lung Cancer Research Studies (38 papers) and Lung Cancer Diagnosis and Treatment (26 papers). Akihiro Bessho collaborates with scholars based in Japan, United States and Taiwan. Akihiro Bessho's co-authors include Katsuyuki Kiura, Mitsune Tanimoto, Hiroshi Ueoka, Katsuyuki Hotta, Nagio Takigawa, Yoshihiko Segawa, Masahiro Tabata, Shingo Harita, Shinobu Hosokawa and Shoichi Kuyama and has published in prestigious journals such as Journal of Clinical Oncology, Blood and PLoS ONE.

In The Last Decade

Akihiro Bessho

86 papers receiving 1.3k citations

Peers

Countries citing papers authored by Akihiro Bessho

Since Specialization

Citations

This map shows the geographic impact of Akihiro Bessho's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Akihiro Bessho with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Akihiro Bessho more than expected).

Fields of papers citing papers by Akihiro Bessho

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Akihiro Bessho. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Akihiro Bessho. The network helps show where Akihiro Bessho may publish in the future.

Co-authorship network of co-authors of Akihiro Bessho

This figure shows the co-authorship network connecting the top 25 collaborators of Akihiro Bessho. A scholar is included among the top collaborators of Akihiro Bessho based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Akihiro Bessho. Akihiro Bessho is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	TCP3 ‐mediated regulation of cell expansion in Arabidopsis thaliana 2025 ·New Phytologist ·Tomotsugu Koyama, Tadashi Kunieda, (unknown), (unknown), Nobutaka Mitsuda, Kouichi Soga, Junko Ishida, Motoaki Seki, Koji Takahashi, Toshinori Kinoshita, Akihiro Bessho, Taku Demura, Masaru Ohme‐Takagi	0
2	Randomized Phase III Study of EGFR Tyrosine Kinase Inhibitor and Intercalated Platinum-Doublet Chemotherapy for Non–Small Cell Lung Cancer Harboring EGFR Mutation 2025 ·Clinical Cancer Research ·Shintaro Kanda, Seiji Niho, Takayasu Kurata, Shogo Nomura, Yosuke Kawashima, Eiji Iwama, Toshihide Yokoyama, Yasutaka Watanabe, Hiroshi Tanaka, Yutaka Fujiwara, Yoshitaka Zenke, Koichi Azuma, Hirokazu Taniguchi, Ryo Toyozawa, Yukio Hosomi, Haruyasu Murakami, (unknown), Akihiro Bessho, Nobuyuki Yamamoto, Yuichiro Ohe	1
3	A phase II study of daily carboplatin plus irradiation followed by durvalumab therapy for older adults (≥75 years) with unresectable III non-small-cell lung cancer and performance status of 2: NEJ039A 2024 ·ESMO Open ·Atsuto Mouri, (unknown), (unknown), Ryo Ko, (unknown), Tomonori Makiguchi, Kazutoshi Isobe, (unknown), Toru Kondo, Minoru Akiyama, Akihiro Bessho, (unknown), Kazuya Yoshimura, Hiroshi Kagamu, Shingo Kato, Kunihiko Kobayashi, (unknown), Makoto Maemondo	1
4	Pembrolizumab and Pemetrexed for Older Patients With Nonsquamous NSCLC and Programmed Cell Death-Ligand 1 Tumor Proportion Scores of Less Than 50% 2024 ·JTO Clinical and Research Reports ·Yoshihito Kogure, Hiroya Hashimoto, Haruko Daga, Yasushi Fukuda, Akihiro Bessho, Tadaaki Yamada, Yukihiro Toi, Tomoki Kimura, Hiroshige Yoshioka, Koichi Azuma, Naoki Furuya, Yasutaka Fukui, Akiko Saito, Nobuyuki Yamamoto, Hideo Saka, Masashi Kondo	0
5	Talc slurry pleurodesis in patients with secondary intractable pneumothorax: A phase 2 study 2024 ·Respiratory Investigation ·Hideo Saka, Masahide Oki, Yoshikane Yamauchi, Chiyoe Kitagawa, Akiko Kada, Akiko Saito, Haruhiko Kondo, Hirotaka Kida, Noriaki Takahashi, Akihiro Bessho, Katsuhiro Okuda, (unknown)	1
6	A Randomized Comparison of Nivolumab versus Nivolumab + Docetaxel for Previously Treated Advanced or Recurrent ICI-Naïve Non–Small Cell Lung Cancer: TORG1630 2022 ·Clinical Cancer Research ·(unknown), Tsuneo Shimokawa, Yuichi Takiguchi, Toshihiro Misumi, Yukiko Nakamura, Yosuke Kawashima, Naoki Furuya, Yoshimasa Shiraishi, Toshiyuki Harada, Hisashi Tanaka, Satoru Miura, (unknown), Yoshiro Nakahara, Takaaki Tokito, Katsuhiko Naoki, Akihiro Bessho, Yasuhiro Gotô, Masahiro Seike, Hiroaki Okamoto	19
7	Pembrolizumab in advanced NSCLC patients with poor performance status and high PD-L1 expression: OLCSG 1801 2022 ·International Journal of Clinical Oncology ·Shinobu Hosokawa, Eiki Ichihara, Daijiro Harada, Shoichi Kuyama, Koji Inoue, Kenichi Gemba, (unknown), Yuka Kato, Naohiro Oda, Isao Oze, Tomoki Tamura, Toshiyuki Kozuki, (unknown), (unknown), Katsuyuki Hotta, Akihiro Bessho, (unknown), Katsuyuki Kiura	4
8	A Randomized Phase II Study Comparing Nivolumab with Carboplatin–Pemetrexed for EGFR -Mutated NSCLC with Resistance to EGFR Tyrosine Kinase Inhibitors (WJOG8515L) 2021 ·Clinical Cancer Research ·Hidetoshi Hayashi, Shunichi Sugawara, Yasushi Fukuda, Daichi Fujimoto, Satoru Miura, Keiichi Ota, Yuichi Ozawa, Satoshi Hara, Junko Tanizaki, Koichi Azuma, Shota Omori, Motoko Tachihara, Kazumi Nishino, Akihiro Bessho, Yasutaka Chiba, Koji Haratani, Kazuko Sakai, Kazuto Nishio, Nobuyuki Yamamoto, Kazuhiko Nakagawa	49
9	Open-label, multicenter, randomized phase II study on docetaxel plus bevacizumab or pemetrexed plus bevacizumab for treatment of elderly (aged ≥75 years) patients with previously untreated advanced non-squamous non-small cell lung cancer: TORG1323 2020 ·Translational Lung Cancer Research ·Toshiyuki Kozuki, Naoyuki Nogami, Osamu Hataji, Yoshio Tsunezuka, (unknown), Toshiyuki Harada, Nobukazu Fujimoto, Akihiro Bessho, Kei Takamura, Kazuhisa Takahashi, Miyako Satouchi, Terufumi Kato, Takehito Shukuya, Natsumi Yamashita, Hiroaki Okamoto, Tetsu Shinkai	4
10	Coronary artery calcification scoring system based on the coronary artery calcium data and reporting system (CAC-DRS) predicts major adverse cardiovascular events or all-cause death in patients with potentially curable lung cancer without a history of cardiovascular disease 2020 ·Heart and Vessels ·Kazuhiro Osawa, Akihiro Bessho, Soichiro Fuke, Shigeharu Moriyama, (unknown), (unknown), Masamichi Tanaka, (unknown), Hironori Saito, Hiroshi Ito	13
11	Phase II Study of Pleurodesis using Sterile Graded Talc in Patients with Secondary Intractable Pneumothorax: Protocol for a Multicentre, Open-label Single-arm Trial 2018 ·Chiyoe Kitagawa, Hideo Saka, Akiko Kada, Akiko Saito, Hidefumi Takei, Noriyuki Matsutani, Noriaki Takahashi, Masamichi Mineshita, Osamu Kawano, Akihiro Bessho, (unknown)	1
12	P3.02b-073 A Phase II, Liquid Biopsy Study Using Digital PCR in EGFR Mutated, Lung Cancer Patients Treated with Afatinib (WJOG 8114LTR) 2017 ·Journal of Thoracic Oncology ·Hiroaki Akamatsu, Yasuhiro Koh, Satoshi Morita, Daichi Fujimoto, Isamu Okamoto, Akihiro Bessho, Koichi Azuma, Kazuhiko Nakagawa, Nobuyuki Yamamoto	1
13	Non–Small Cell Lung Cancer Cells Acquire Resistance to the ALK Inhibitor Alectinib by Activating Alternative Receptor Tyrosine Kinases 2016 ·Cancer Research ·Hideko Isozaki, Eiki Ichihara, Nagio Takigawa, Kadoaki Ohashi, Nobuaki Ochi, Masayuki Yasugi, Takashi Ninomiya, Hiromichi Yamane, Katsuyuki Hotta, Katsuya Sakai, Kunio Matsumoto, Shinobu Hosokawa, Akihiro Bessho, Toshiaki Sendo, Mitsune Tanimoto, Katsuyuki Kiura	109
14	Gefitinib Combined With Standard Chemoradiotherapy in EGFR-Mutant Locally Advanced Non–Small-Cell Lung Cancer: The LOGIK0902/OLCSG0905 Intergroup Study Protocol 2015 ·Clinical Lung Cancer ·Katsuyuki Hotta, Jiichiro Sasaki, Sho Saeki, Nagio Takigawa, Kuniaki Katsui, Koichi Takayama, Naoyuki Nogami, Yoshiyuki Shioyama, Akihiro Bessho, Junji Kishimoto, Mitsune Tanimoto, Katsuyuki Kiura, Yukito Ichinose	11
15	A Phase II Trial of Erlotinib Monotherapy in Pretreated Patients with Advanced Non-small Cell Lung Cancer Who Do Not Possess Active EGFR Mutations: Okayama Lung Cancer Study Group Trial 0705 2010 ·Journal of Thoracic Oncology ·Hiroshige Yoshioka, Katsuyuki Hotta, Katsuyuki Kiura, Nagio Takigawa, Hidetoshi Hayashi, Shingo Harita, Shoichi Kuyama, Yoshihiko Segawa, Haruhito Kamei, Shigeki Umemura, Akihiro Bessho, Masahiro Tabata, Mitsune Tanimoto	56
16	Continued gefitinib treatment after disease stabilisation prolongs survival of Japanese patients with non-small-cell lung cancer: Okayama Lung Cancer Study Group experience 2005 ·Annals of Oncology ·Katsuyuki Hotta, Keitaro Matsuo, Hiroshi Ueoka, Katsuyuki Kiura, Masahiro Tabata, Shingo Harita, Kenichi Gemba, (unknown), Akihiro Bessho, Mitsune Tanimoto	21
17	Multiple Ground-Glass Opacity in Metastasis of Malignant Melanoma Diagnosed By Lung Biopsy 2004 ·The Annals of Thoracic Surgery ·Riki Okita, Motohiro Yamashita, Masao Nakata, Norihiro Teramoto, Akihiro Bessho, H Mogami	35
18	Parathyroid hormone‐related protein measured at the time of first visit is an indicator of bone metastases and survival in lung carcinoma patients with hypercalcemia 2002 ·Cancer ·Akio Hiraki, Hiroshi Ueoka, Akihiro Bessho, Yoshihiko Segawa, Nagio Takigawa, Katsuyuki Kiura, Kenji Eguchi, Toshiyuki Yoneda, Mitsune Tanimoto, Mine Harada	53
19	Intramedullary spinal cord recurrence after high-dose chemotherapy and autologous peripheral blood progenitor cell transplantation for limited-disease small cell lung cancer 2000 ·Lung Cancer ·Nobukazu Fujimoto, Akio Hiraki, Hiroshi Ueoka, Katsuyuki Kiura, Akihiro Bessho, Ichiro Takata, Yasushi Hiramatsu, Kazuma Ikeda, (unknown)	7
20	The effects of a simplified method for cryopreservation and thawing procedures on peripheral blood stem cells 1997 ·Bone Marrow Transplantation ·Yoshio Katayama, Tomonori Yano, Akihiro Bessho, (unknown), Kazutaka Sunami, (unknown), Katsuji Shinagawa, Eijiro Omoto, Shigeyoshi Makino, Toshihiro Miyamoto, Shin-ichi Mizuno, T. Fukuda, Tetsuya Eto, Tomoaki Fujisaki, Yoshinori Ohno, Shinji Inaba, Y Niho, M Harada	73

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact